Company logo Company name logo
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.     |     Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors.     |     KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |     ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
 
Concord Biotech LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543960NSE Symbol: CONCORDBIOP/E(TTM):42.09
ISIN Demat:INE338H01029Div & Yield %:0.63EPS(TTM):14.2
Book Value(Rs):99.7123352Market Cap (rupee Cr.):12504.77Face Value(Rs):1
    
Date Headline
28-Oct-26 Concord Biotech consolidated net profit rises 11.12% in the September 2026 quarter
22-Oct-26 Concord Biotech schedules board meeting
19-Sep-26 Concord Biotech to consider bonus
18-Sep-26 Concord Biotech's Valthera unit completes US FDA audit with one procedural observation
18-Sep-26 Indices end sideways; metal shares shine for 3rd day
31-Aug-26 Volumes spurt at Concord Biotech Ltd counter
01-Aug-26 Concord Biotech consolidated net profit rises 32.84% in the June 2026 quarter
29-Jul-26 Concord Biotech to discuss results
08-Jul-26 Concord Biotech schedules AGM
07-Jul-26 Concord Biotech fixes record date for final dividend
<< < 1 2 3 4 > >>